Peptide Receptor Radionuclide Therapy: An Emerging Treatment for Gastrointestinal Neuroendocrine Tumors
肽受体核素疗法:一种治疗胃肠神经内分泌肿瘤的新兴疗法
作者: Adria Myers Holly Renea Chitwood
刊名: Clinical Journal of Oncology Nursing, 2020, Vol.24 (2)
来源数据库: Oncology Nursing Society
DOI: 10.1188/20.CJON.129-133
关键词: Peptide receptor radionuclide therapy (PRRT)NeuroendocrineCarcinoid syndrome
原始语种摘要: Neuroendocrine tumors (NETs) are comprised of biologically diverse neoplasms. The presence of systemic symptoms is dependent on NET location and differentiation. New treatment modalities have become available, offering patients improved symptom management and survival. Advanced practice RNs (APRNs) provide direct care to and coordination of treatment for patients with NETs, including treatment of somatostatin receptor–positive disease with lutetium Lu 177 dotatate (Lutathera®) peptide receptor radionuclide therapy.
全文获取路径: PDF下载  ONS 
分享到:
来源刊物:
影响因子:0.91 (2012)

×
关键词翻译
关键词翻译
  • receptor 接受体
  • radionuclide 放射性核素
  • lutetium 
  • treatment 处理
  • coordination 配位
  • provide 规定
  • systemic 系统的
  • peptide 
  • survival 生存
  • including 包括(气导)包括……在内包括…在内